Generic Peptides

In addition, CPC specializes in the production of lanreotide therapy on an
industrial scale, following the CGMP's (Current Good Manufacturing Practices).
Our expertise allows us to manufacture a range of high-quality generic peptides
at a commercial scale. With stringent quality control measures in place, we
ensure consistent and reliable production of generic peptides that meet
regulatory standards.

Our Generic API Portfolio:
　Disease Area API Indication DMF Status
Tumour Leuprorelin Acetate Prostate & Breast Cancer; 
Endometriosis; Uterine Leiomyomata; 
Precocious Puberty MFDS: 20200625-210-J-661            

Click to Enlarge